Mo, D., Huang, J., Luo, P., Huang, S., & Wang, H. (2021). Combination therapy with immune checkpoint inhibitors in advanced renal cell carcinoma: A meta-analysis of randomized controlled trials. Clinical immunology (Orlando, Fla.), 232, 108876. https://doi.org/10.1016/j.clim.2021.108876
Style de citation ChicagoMo, Dun-Chang, Jian-Feng Huang, Peng-Hui Luo, Shang-Xiao Huang, et Han-Lei Wang. "Combination Therapy with Immune Checkpoint Inhibitors in Advanced Renal Cell Carcinoma: A Meta-analysis of Randomized Controlled Trials." Clinical Immunology (Orlando, Fla.) 232 (2021): 108876. https://dx.doi.org/10.1016/j.clim.2021.108876.
Style de citation MLAMo, Dun-Chang, et al. "Combination Therapy with Immune Checkpoint Inhibitors in Advanced Renal Cell Carcinoma: A Meta-analysis of Randomized Controlled Trials." Clinical Immunology (Orlando, Fla.), vol. 232, 2021, p. 108876.